
1.66 Delayed Data As of Jun 29 | ![]() Today’s Change | 1.08 Today|||52-Week Range 3.58 | -16.58% Year-to-Date |
ObsEva's (OBSV) Yselty Gets EU Nod to Treat Uterine Fibroids Jun 17 / Zacks.com - Paid Partner Content |
Previous close | 1.72 |
Today’s open | 1.71 |
Day’s range | 1.63 - 1.71 |
Volume | 516,502 |
Average volume (3 months) | 517,652 |
Market cap | $154.4M |
Earnings growth (last year) | +53.44% |
Earnings growth (this year) | 0.00% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 4.34 |
Today’s change | Today’s % change | |
---|---|---|
CTXRCitius Pharmaceutica... | -0.04 | -3.69% |
AVDLAvadel Pharmaceutica... | 0.00 | 0.00% |
---- | ||
FSTXF-Star Therapeutics ... | +0.06 | +0.96% |
Next reporting date | August 10, 2022 |
EPS forecast (this quarter) | -$0.19 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$58.4M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Geneva, Geneve (geneva) |